Marcum Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $2.79M | Buy |
3,375
+22
| +0.7% | +$18.2K | 0.24% | 48 |
|
2024
Q4 | $2.59M | Buy |
3,353
+209
| +7% | +$161K | 0.22% | 51 |
|
2024
Q3 | $2.79M | Buy |
3,144
+247
| +9% | +$219K | 0.26% | 45 |
|
2024
Q2 | $2.62M | Sell |
2,897
-20
| -0.7% | -$18.1K | 0.26% | 44 |
|
2024
Q1 | $2.27M | Buy |
2,917
+196
| +7% | +$152K | 0.23% | 48 |
|
2023
Q4 | $1.59M | Buy |
2,721
+155
| +6% | +$90.4K | 0.17% | 66 |
|
2023
Q3 | $1.38M | Sell |
2,566
-101
| -4% | -$54.3K | 0.17% | 69 |
|
2023
Q2 | $1.25M | Buy |
2,667
+61
| +2% | +$28.6K | 0.15% | 77 |
|
2023
Q1 | $895K | Buy |
2,606
+34
| +1% | +$11.7K | 0.11% | 105 |
|
2022
Q4 | $941K | Sell |
2,572
-1,572
| -38% | -$575K | 0.12% | 91 |
|
2022
Q3 | $1.34M | Buy |
4,144
+43
| +1% | +$13.9K | 0.2% | 60 |
|
2022
Q2 | $1.33M | Buy |
4,101
+343
| +9% | +$111K | 0.2% | 63 |
|
2022
Q1 | $1.08M | Sell |
3,758
-42
| -1% | -$12K | 0.15% | 90 |
|
2021
Q4 | $1.05M | Buy |
3,800
+11
| +0.3% | +$3.04K | 0.15% | 100 |
|
2021
Q3 | $875K | Sell |
3,789
-483
| -11% | -$112K | 0.14% | 105 |
|
2021
Q2 | $981K | Buy |
4,272
+187
| +5% | +$42.9K | 0.16% | 98 |
|
2021
Q1 | $763K | Buy |
4,085
+802
| +24% | +$150K | 0.13% | 120 |
|
2020
Q4 | $554K | Buy |
3,283
+143
| +5% | +$24.1K | 0.13% | 61 |
|
2020
Q3 | $465K | Sell |
3,140
-1,816
| -37% | -$269K | 0.14% | 51 |
|
2020
Q2 | $814K | Buy |
4,956
+3,405
| +220% | +$559K | 0.25% | 41 |
|
2020
Q1 | $215K | Buy |
1,551
+10
| +0.6% | +$1.39K | 0.08% | 83 |
|
2019
Q4 | $203K | Buy |
+1,541
| New | +$203K | 0.08% | 98 |
|